Nature Communications (May 2021)

Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice

  • Alexandra J. Spencer,
  • Paul F. McKay,
  • Sandra Belij-Rammerstorfer,
  • Marta Ulaszewska,
  • Cameron D. Bissett,
  • Kai Hu,
  • Karnyart Samnuan,
  • Anna K. Blakney,
  • Daniel Wright,
  • Hannah R. Sharpe,
  • Ciaran Gilbride,
  • Adam Truby,
  • Elizabeth R. Allen,
  • Sarah C. Gilbert,
  • Robin J. Shattock,
  • Teresa Lambe

DOI
https://doi.org/10.1038/s41467-021-23173-1
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 8

Abstract

Read online

Heterologous vaccination regimens for COVID-19 could be useful for example if there is a shortage of one vaccine type. Here, Spencer et al. show that heterologous vaccination with a self-amplifying RNA vaccine and an adenoviral vectored vaccine performs at least as well as the homologous vaccinations in mice.